Historical Stock Price
AVIR historical stock prices picture
Atea Pharmaceuticals (AVIR) has the following price history information. Looking back at AVIR historical stock prices for the last five trading days, on March 22, 2024, AVIR opened at $4.10, traded as high as $4.13 and as low as $3.98, and closed at $4.06. Trading volume was a total of 254.70K shares. On March 25, 2024, AVIR opened at $3.85, traded as high as $4.05 and as low as $3.79, and closed at $3.82. Trading volume was a total of 592.70K shares. On March 26, 2024, AVIR opened at $3.84, traded as high as $3.89 and as low as $3.77, and closed at $3.77. Trading volume was a total of 242.60K shares. On March 27, 2024, AVIR opened at $3.91, traded as high as $4.04 and as low as $3.87, and closed at $4.00. Trading volume was a total of 367.40K shares. On March 28, 2024, AVIR opened at $3.98, traded as high as $4.09 and as low as $3.98, and closed at $4.04. Trading volume was a total of 374.00K shares.

AVIR Historical Stock Prices By Date:

AVIR historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Atea Pharmaceuticals shares, starting with a $10,000 purchase of AVIR, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/30/2020
End date: 03/28/2024
Start price/share: $30.34
End price/share: $4.04
Dividends collected/share: $0.00
Total return: -86.68%
Average Annual Total Return: -44.63%
Starting investment: $10,000.00
Ending investment: $1,331.43
Years: 3.41
Date Open High Low Close Volume
03/22/2024 $4.10 $4.13 $3.98 $4.06 254.70K
03/25/2024 $3.85 $4.05 $3.79 $3.82 592.70K
03/26/2024 $3.84 $3.89 $3.77 $3.77 242.60K
03/27/2024 $3.91 $4.04 $3.87 $4.00 367.40K
03/28/2024 $3.98 $4.09 $3.98 $4.04 374.00K
Atea Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Co's existing focus is on the development of product candidates to treat COVID-19, hepatitis C virus (HCV), dengue and respiratory syncytial virus. Co.'s product candidate for the treatment of COVID-19 is bemnifosbuvir. For the treatment of chronic HCV infection, Co. is developing a combination of bemnifosbuvir and ruzasvir, an investigational nonstructural protein 5A inhibitor. Co. is developing AT-752, an oral, purine nucleotide prodrug for the treatment of dengue.
Date Close
03/22/2024$4.06
03/25/2024$3.82
03/26/2024$3.77
03/27/2024$4.00
03/28/2024$4.04
AVIR is categorized under the Healthcare sector; below are some other companies in the same sector:

AVNR Historical Stock Prices
AVXL Historical Stock Prices
AVXS Historical Stock Prices
AXDX Historical Stock Prices
AXGN Historical Stock Prices
AXN Historical Stock Prices
AXSM Historical Stock Prices
AYTU Historical Stock Prices
AZN Historical Stock Prices
AZRX Historical Stock Prices

Email EnvelopeFree AVIR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


AVIR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.